Retention and outcomes of National Diabetes Prevention Program enrollees and non-enrollees with prediabetes: The University of Michigan experience.

Abstract

AIMS:

To evaluate retention and outcomes of insured adults with prediabetes who enrolled or did not enroll in National Diabetes Prevention Programs (NDPPs).

METHODS:

Between 2015 and 2019, 776 University of Michigan employees, dependents, and retirees with prediabetes and overweight or obesity enrolled in one-year NDPPs.

RESULTS:

Enrollees attended a median of 18 sessions. Median retention was 38 weeks. Retention was associated with older age, greater initial weight loss, and physical activity. At both 1- and 2-years, body mass index, triglycerides, and HbA1c were significantly improved among enrollees. After adjusting for age group, sex, and race, the odds of developing diabetes based on HbA1c ≥6.5 % was 40 % lower at 1-year and 20 % lower at 2-years, and the odds of self-reported diabetes was 57 % lower at 1-year and 46 % lower at 2-years in enrollees compared to non-enrollees. Enrollees who disenrolled before completing the core curriculum had higher odds and enrollees who completed the NDPP had lower odds of developing diabetes that non-enrollees.

CONCLUSIONS:

In this population with prediabetes, NDPP retention was generally good, risk factors were improved, and diabetes was delayed or prevented for up to two years.

• Authors: William H Herman, Claudia Villatoro, Kevin L Joiner, Laura N McEwen
• Journal: Journal of diabetes and its complications (J Diabetes Complications) Vol. 37 Issue 8 Pg. 108527 (08 2023) ISSN: 1873-460X [Electronic] United States
• PMID: 37459781 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
• Copyright: Copyright © 2023. Published by Elsevier Inc.

Chemical References

• 4-nitro-3-dimethylaminopropiophenone
• Glycated Hemoglobin
• Nitro Compounds

Topics

• Adult
• Humans
• Diabetes Mellitus, Type 2 (complications, epidemiology, prevention & control)
• Glycated Hemoglobin
• Nitro Compounds
• Prediabetic State (complications, epidemiology, therapy)
• Male
• Female